| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Air pollution and risk of hospital outpatient visits for eczematous skin disorders in metropolitan cities of South Korea | 하경화 |
| 2021 | | Effect of teneligliptin versus sulfonylurea on major adverse cardiovascular outcomes in people with type 2 diabetes mellitus: A real-world study in Korea | 김대중, 하경화 |
| 2021 | | Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings | 김대중, 하경화 |
| 2021 | | Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 2021 | | Cardiovascular safety of sodium glucose cotransporter 2 inhibitors as add-on to metformin monotherapy in patients with type 2 diabetes mellitus | 김대중, 전자영, 하경화 |
| 2021 | | Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study | 김대중, 이나미, 하경화, 한승진 |
| 2021 | | Trends in the effects of pre-transplant diabetes on mortality and cardiovascular events after kidney transplantation | 박범희, 오창권, 전자영, 하경화, 한승진 |
| 2021 | | Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study | 김대중, 하경화 |
| 2020 | | Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | 김대중, 하경화 |
| 2020 | | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database | 하경화 |
| 2020 | | Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea | 김대중, 박인휘, 이민정, 하경화 |
| 2020 | | Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study | 김대중, 하경화 |
| 2020 | | Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640-8) | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Diabetes and the Risk of Infection: A National Cohort Study | 김대중, 김은진, 최영화, 하경화 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status | 김대중, 하경화 |
| 2019 | | Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study | 김대중, 이기황, 정유리, 하경화 |
| 2019 | | Cohort Profile: The Cardiovascular and Metabolic Diseases Etiology Research Center Cohort in Korea | 김대중, 하경화 |
| 2019 | | Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study | 김대중, 하경화 |
